In 13 families, iPPSD2 was diagnosed based on PTH resistance and AHO manifestation, and in 10 of the 13 families, it was based on molecular evaluation of the GNAS gene (Table 1). This evidence concerns the gene GNAS and pseudohypoparathyroidism type 1A.